Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation ; volume:196 ; number:3 ; day:19 ; month:10 ; year:2022 ; pages:471-482 ; date:12.2022
Breast cancer research and treatment ; 196, Heft 3 (19.10.2022), 471-482, 12.2022
- Urheber
-
Vihervuori, H.
Korpinen, K.
Autere, T. A.
Repo, H.
Talvinen, K.
Kronqvist, P.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-022-06767-1
- URN
-
urn:nbn:de:101:1-2023011821125664066785
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vihervuori, H.
- Korpinen, K.
- Autere, T. A.
- Repo, H.
- Talvinen, K.
- Kronqvist, P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway
MicroRNA signatures in triple-negative breast cancer
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway
MicroRNA signatures in triple-negative breast cancer
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway